Dr. Kenneth Gordon Sands, DO

Dr. Sands practices at University of Virginia Physicians Group in Charlottesville, Virginia.

Dr. Sands' NPI, 1861804098, was assigned on May 22, 2014. Dr. Sands graduated from Lincoln Mem Univ, Debusk Col of Osteopathic Med in 2014. Dr. Sands holds Virginia license 0102207781.

Dr. Sands' primary practice is University of Virginia Physicians Group, at 500 Ray C Hunt Dr, Charlottesville, VA 22903 in Charlottesville City. The practice phone is (434) 295-1000.

Dr. Sands' primary practice is University of Virginia Physicians Group in Charlottesville, Virginia. Dr. Sands is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Sands to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sands practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Sands' primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Sands' licenses on file in 2 states: Virginia and Missouri.

CMS data shows 798 Medicare services from Dr. Sands across 13 procedure codes in 2024, for 394 Medicare patients. Medicare paid $63,079 for them.

CMS counts 394 Medicare patients who saw Dr. Sands in 2024. The largest group is 65 to 74, with 164 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sands' median patient age at 65, with 39% women.

In 2024, Dr. Sands wrote 304 Medicare Part D claims for 148 patients. 94% of them were for generic drugs. CMS names the drug for 204 of them, across 8 drugs with 11 or more claims each, at $10,154 in total drug cost. In 2023, CMS named 468 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Sands for performance year 2024, reported as part of a group. Dr. Sands accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sands as offering telehealth. CMS counts 12 procedures of prostate resection by Dr. Sands, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. Sands, published from 2020 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Kidney Neoplasms, Nephrectomy and Robotics. Dr. Sands has published most often in J Endourol. Dr. Sands' most frequent co-authors are Eric Kim, DDS, MD, Ramakrishna Venkatesh, MD and Robert S. Figenshau, MD.

CMS Open Payments shows 98 general payments to Dr. Sands from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Boston Scientific Corporation paid the most, $2,792.

Dr. Sands graduated from Lincoln Mem Univ, Debusk Col of Osteopathic Med in 2014.